75F40125D00003

FFP - SINGLE AWARD IDIQ - CDER - OFFICE OF CLINICAL PHARMACOLOGY CLINICAL STUDIES AND LABORATORY SUPPORT

Award details

Obligations, current value and potential value describe different measures; they are never added together.

Field	Reported value
Agency	Department of Health and Human Services
Office	FDA OFFICE OF ACQ GRANT SVCS
NAICS	541714 — Research and Development in Biotechnology (except Nanobiotechnology)
PSC	AJ12 — GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; APPLIED RESEARCH
Parent award / vehicle	Not reported
Set-aside	SMALL BUSINESS SET ASIDE - TOTAL
Pricing type	FIRM FIXED PRICE
Obligations	$2.5K
Current contract value	Not reported
Potential contract value / ceiling	$50.0M
Start date	Sep 15, 2025
Current end date	Not available
Potential end date	Not available
Latest award activity	Oct 20, 2025
Source loaded	Sep 26, 2026

Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.

Date	Modification	Obligation change	Description
Oct 20, 2025	P00001	$0	CONVERT A PORTION OF MINIMUM GUARANTEE RESERVED FUNDS FOR AWARD KICK-OFF MEETING
Sep 15, 2025	0	$2.5K	FFP - SINGLE AWARD IDIQ - CDER - OFFICE OF CLINICAL PHARMACOLOGY CLINICAL STUDIES AND LABORATORY SUPPORT

Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.

Contact	Role	Published contact methods	Evidence	Source date
Craig Wright	Contact	craig.wright@fda.hhs.gov 240-402-3996	Source	Aug 15, 2024
Ian Weiss	Contact	Ian.Weiss@fda.hhs.gov 3017965728	Source	Aug 15, 2024
Craig Wright	Contact	craig.wright@fda.hhs.gov 240-402-3996	Source	Jul 18, 2024
Ian Weiss	Contact	Ian.Weiss@fda.hhs.gov 3017965728	Source	Jul 18, 2024